EQS-News: Newron Pharmaceuticals S.p.A. / Key word: Conference/Study results
Newron presents exciting new data from study 014/015 at CINP World Congress of Neuropsychopharmacology and. | May 15, 2023
Ad hoc announcement pursuant to Art. 53 LR Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients